We are live on ! Find out more
GW

GW & Wade Portfolio holdings

AUM $3.08B
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$1.1B
AUM Growth
+$42.2M
Cap. Flow
+$12.2M
Cap. Flow %
1.11%
Top 10 Hldgs %
33.6%
Holding
243
New
14
Increased
122
Reduced
64
Closed
9

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$10.2M
2
MDT icon
Medtronic
MDT
+$8.87M
3
SO icon
Southern Company
SO
+$5.12M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$3.51M
5
WMT icon
Walmart Inc
WMT
+$2.33M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$10.3M
2
CCI icon
Crown Castle
CCI
+$8.95M
3
AMGN icon
Amgen
AMGN
+$4.4M
4
VOD icon
Vodafone
VOD
+$2.5M
5
TRV icon
Travelers Companies
TRV
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 11.55%
2 Industrials 8.04%
3 Energy 7.64%
4 Consumer Staples 7.19%
5 Healthcare 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWD icon
26
iShares Russell 1000 Value ETF
IWD
$81.9B
$12.7M 1.16%
100,171
+242
+0.2% +$30.3K
IJH icon
27
iShares Core S&P Mid-Cap ETF
IJH
$122B
$12.7M 1.16%
327,950
+20,295
+7% +$778K
MET icon
28
MetLife
MET
$60.5B
$12.4M 1.13%
250,105
+3,436
+1% +$162K
KO icon
29
Coca-Cola
KO
$351B
$12.3M 1.11%
240,661
+1,554
+0.6% +$76.2K
CL icon
30
Colgate-Palmolive
CL
$74.4B
$11.6M 1.06%
162,528
-141
-0.1% -$10K
AMGN icon
31
Amgen
AMGN
$198B
$10.8M 0.98%
58,415
-24,563
-30% -$4.4M
QQQ icon
32
Invesco QQQ Trust
QQQ
$466B
$10.5M 0.96%
56,278
+1,138
+2% +$209K
T icon
33
AT&T
T
$152B
$10.4M 0.95%
412,503
+22,204
+6% +$533K
UPS icon
34
United Parcel Service
UPS
$100B
$10.4M 0.95%
101,020
-415
-0.4% -$43.2K
JPEM icon
35
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$378M
$10.4M 0.94%
186,768
+4,079
+2% +$222K
ACN icon
36
Accenture
ACN
$87.9B
$10.3M 0.93%
55,550
-174
-0.3% -$31.3K
EXR icon
37
Extra Space Storage
EXR
$31.3B
$10M 0.91%
94,307
+4,435
+5% +$466K
QCOM icon
38
Qualcomm
QCOM
$181B
$10M 0.91%
131,511
+24
+0% +$1.76K
IP icon
39
International Paper
IP
$19.9B
$9.9M 0.9%
241,329
+3,261
+1% +$138K
MDT icon
40
Medtronic
MDT
$106B
$9.83M 0.89%
100,903
+97,139
+2,581% +$8.87M
WFC icon
41
Wells Fargo
WFC
$265B
$9.71M 0.88%
205,287
+2,759
+1% +$129K
IWB icon
42
iShares Russell 1000 ETF
IWB
$48B
$9.6M 0.87%
58,939
+2,963
+5% +$474K
CVX icon
43
Chevron
CVX
$373B
$9.16M 0.83%
73,631
+182
+0.2% +$22K
VEA icon
44
Vanguard FTSE Developed Markets ETF
VEA
$226B
$8.88M 0.81%
212,931
+10,609
+5% +$437K
JPM icon
45
JPMorgan Chase
JPM
$907B
$8.52M 0.77%
76,199
-399
-0.5% -$44K
KMB icon
46
Kimberly-Clark
KMB
$36B
$7.97M 0.72%
59,818
+910
+2% +$117K
AMZN icon
47
Amazon
AMZN
$2.66T
$7.93M 0.72%
83,760
+3,080
+4% +$287K
CVS icon
48
CVS Health
CVS
$137B
$7.78M 0.71%
142,829
-3,417
-2% -$184K
VNQ icon
49
Vanguard Real Estate ETF
VNQ
$39.6B
$7.4M 0.67%
84,623
+4,257
+5% +$373K
IEF icon
50
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
$7.32M 0.67%
66,564
+1,450
+2% +$155K

Similar funds

GW & Wade's Q2 2019 Portfolio in Review

As of Q2 2019, GW & Wade held 243 positions worth $1.1B, up 4% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

GW & Wade's Q2 2019 filing shows 14 new, 122 increased, 64 reduced and 9 closed positions. Its largest new stake was GSK: 15,322 shares worth $767K. The largest sale was 3M, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.

  • GW & Wade's largest Q2 2019 buy was GSK: 15,322 shares worth $767K.
  • GW & Wade added most to Pfizer in Q2 2019, an estimated $10.2M increase.
  • GW & Wade's biggest Q2 2019 reduction was 3M, cutting an estimated $10.3M.
  • GW & Wade fully exited Crown Castle in Q2 2019, selling an estimated $8.95M.
  • GW & Wade's ten largest holdings make up 34% of its $1.1B portfolio in Q2 2019.
  • GW & Wade opened 14 new positions and closed 9 in Q2 2019.
  • GW & Wade's portfolio value rose 4% quarter-over-quarter to $1.1B.

Based on GW & Wade's 13F filing for Q2 2019, filed 12 Aug 2019.